MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
종목 코드 MDXG
회사 이름MiMedx Group Inc
상장일Aug 20, 2007
CEOCapper (Joseph H)
직원 수837
유형Ordinary Share
회계 연도 종료Aug 20
주소1775 W Oak Commons Court, Ne
도시MARIETTA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호30062
전화17706519100
웹사이트https://mimedx.com/
종목 코드 MDXG
상장일Aug 20, 2007
CEOCapper (Joseph H)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음